Analysis of non-HLA genomic risk factors in HLA-matched unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia

BACKGROUND: Allogeneic hematopoietic cell transplantation is the main curative therapy for patients with chronic myeloid leukemia who do not respond to tyrosine kinase inhibitors. It has been proposed that non-human leukocyte antigen gene polymorphisms influence outcome after hematopoietic cell tran...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Pearce, Kim F., Lee, Stephanie J., Haagenson, Michael, Petersdorf, Effie W., Norden, Jean, Collin, Matthew P., Klein, John P., Spellman, Stephen R., Lowerson, Shelagh A., Davies, Stella, Dickinson, Anne M.
Format: Artigo
Langue:Inglês
Publié: Ferrata Storti Foundation 2012
Sujets:
Original Articles and Brief Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3396672/
https://ncbi.nlm.nih.gov/pubmed/22271889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.053611
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires